Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptima Health Regulatory News (OPT)

Share Price Information for Optima Health (OPT)

Share Price is delayed by 15 minutes
Get Live Data
187.00    0.00 (0.00%)
Bid:
185.00
Ask:
189.00
Spread: 4.00 (2.162%)
Market Cap: £203.41m
OPT Live PriceLast checked at - London Stock Exchange

Intraday Optima Health Share Chart

Interim Results

31 Jan 2007 16:03

Ocean Power Technologies Inc31 January 2007 Ocean Power Technologies, Inc. 1590 Reed Road Pennington, New Jersey 08534 USA For Immediate Release 31 January 2007 OCEAN POWER TECHNOLOGIES ANNOUNCES RESULTS FOR THE SIX MONTHS ENDED 31 OCTOBER 2006 Ocean Power Technologies, Inc ("OPT" or the "Company") (London Stock Exchange:AIM-OPT), announced today its results for the six months ended 31 October 2006.Contract backlog for the Company was $5.0 million as of 31 October 2006, ascompared to $2.8 million as of 31 October 2005. About Ocean Power Technologies Ocean Power Technologies, Inc. develops and is commercializing proprietarysystems that generate electricity by harnessing the renewable energy of oceanwaves. The Company's PowerBuoy(R) system is based on modular, ocean-going buoys,which have been ocean tested for nearly a decade. For further information, please contact: Ocean Power Technologies, Inc Dr. George W. Taylor, Chief Executive Officer Telephone: +1 609 730 0400Charles F. Dunleavy, Chief Financial Officer Telephone: +1 609 730 0400 Corfin Communications Ben Hunt, Neil Thapar Telephone: +44 20 7929 8989 Consolidated Balance Sheets as ofOctober 31, 2005 and October 31, 2006 Oct 31, 2005 Oct 31, 2006 (Unaudited) (Unaudited) $ $ Cash and cash equivalents 3,882,319 18,250,604Certificates of deposit 31,311,409 10,927,992Accounts receivable 136,818 383,869Unbilled receivables 332,976 368,671Other current assets 330,036 1,512,924 Total current assets 35,993,558 31,444,060 Property and equipment 537,914 446,963Patents, net of accumulated amortization of$147,539 and $167,077, respectively 345,788 515,137 OTHER NONCURRENT ASSETS 88,837 278,944 TOTAL ASSETS 36,966,097 32,685,104 LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES:Accounts payable 404,030 1,167,263Accrued expenses 1,596,909 2,671,965Unearned revenues 166,671 108,791Other current liabilities 53,773 50,526 Total current liabilities 2,221,383 3,998,545 LONG-TERM DEBT 240,357 233,959 DEFERRED RENT - 8,118 DEFERRED CREDITS 600,000 600,000 Total liabilities 3,061,740 4,840,622 COMMITMENTS AND CONTINGENCIES STOCKHOLDERS' EQUITY:Preferred stock, $0.001 par value; authorized5,000,000 shares; none issued or outstanding - - Common stock, $0.001 par value; authorized105,000,000 shares; issued and outstanding 51,599,441 and 51,766,941 shares, respectively 51,599 51,767 Additional paid-in capital 59,488,709 60,436,657Accumulated deficit (25,633,514) (32,600,307)Accumulated other comprehensive loss (2,437) (43,635) Total stockholders' equity 33,904,357 27,844,482 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 36,966,097 32,685,104 Consolidated Statements of OperationsFor the six months ended October 31, 2005 and 2006 Oct 31, 2005 Oct 31, 2006 (Unaudited) (Unaudited) $ $ REVENUES 1,106,499 860,747COST OF REVENUES 1,506,634 1,382,630 Gross loss (400,135) (521,883) PRODUCT DEVELOPMENT COSTS 1,551,638 2,802,039 SELLING, GENERAL ANDADMINISTRATIVE COSTS 1,434,294 2,013,137 Operating loss (3,386,067) (5,337,059) INTEREST INCOME, NET 709,457 722,928 OTHER INCOME 75,000 - FOREIGN EXCHANGE (LOSS)GAIN (1,446,790) 645,977 NET LOSS (4,048,400) (3,968,154) Consolidated Statements of Cash FlowsFor the six months ended October 31, 2005 and2006 Oct 31, 2005 Oct 31, 2006 (Unaudited) (Unaudited)CASH FLOWS FROM OPERATING ACTIVITIES: $ $ Net loss (4,048,400) (3,968,154) Adjustments to reconcile net loss to net cashused in operating activities: Foreign exchange loss (gain) 1,446,790 (645,977)Depreciation and amortization 84,465 131,340Loss on disposal of equipment - 20,344Compensation expense related to stock option grants - 709,951Realization of deferred credits (75,000) -Deferred rent - 8,118 Changes in operating assets and liabilities: Accounts receivable 531,606 (378,228)Unbilled receivables 489,061 (157,311)Other current assets 137,144 (1,179,849)Accounts payable (472,938) 843,332Accrued expenses (300,060) 930,928Unearned revenues 149,883 92,727Other current liabilities - (61,050) Net cash used in operating activities (2,057,449) (3,653,829) CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of certificates of deposit (37,194,886) (39,890,009)Maturities of certificates of deposit 31,085,839 29,444,173Purchases of equipment (184,919) (44,736)Payments of patent costs (20,826) (73,202)Investments in joint ventures and other noncurrent assets 309 (178,161) Net cash used in investing activities (6,314,483) (10,741,935) CASH FLOWS FROM FINANCING ACTIVITES: Proceeds from exercise of stock options 111,202 47,525 Net cash provided by financing activities 111,202 47,525 EFFECT OF EXCHANGE RATE CHANGES ON CASH ANDCASH EQUIVALENTS (1,441,765) 641,634 NET DECREASE IN CASH AND CASH EQUIVALENTS (9,702,495) (13,706,605) CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 13,584,814 31,957,209 CASH AND CASH EQUIVALENTS, END OF PERIOD 3,882,319 18,250,604 ****** This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th May 20268:34 amRNSHolding(s) in Company
27th May 202612:40 pmRNSHolding(s) in Company
18th May 202610:51 amRNSHolding(s) in Company
13th May 202612:12 pmRNSHolding(s) in Company
12th May 20265:32 pmRNSHolding(s) in Company
12th May 20261:00 pmRNSHolding(s) in Company
5th May 202610:22 amRNSHolding(s) in Company
5th May 20268:58 amRNSHolding(s) in Company
30th Apr 20263:36 pmRNSHolding(s) in Company
29th Apr 20266:02 pmRNSHolding(s) in Company
28th Apr 202610:39 amRNSHolding(s) in Company
28th Apr 20267:00 amRNSDirector/PDMR Shareholding
27th Apr 20264:27 pmRNSHolding(s) in Company
27th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 20263:57 pmRNSResult of GM and Underwritten Open Offer
17th Apr 20267:00 amRNSFull Year Trading Update
31st Mar 20267:00 amRNSLaunch of Underwritten Open Offer
30th Mar 20263:20 pmRNSHolding(s) in Company
24th Mar 20264:37 pmRNSIrish FDI Clearance & Expected Acquisition of PAM
23rd Mar 20267:00 amRNSDirectorate Change
12th Mar 20264:04 pmRNSHolding(s) in Company- Replacement
12th Mar 20267:00 amRNSContract Win
12th Mar 20267:00 amRNSContract Win
5th Mar 20263:50 pmRNSHolding(s) in Company
4th Mar 20263:33 pmRNSHolding(s) in Company
24th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Feb 20267:00 amRNSAppointment of Joint Broker
16th Feb 20267:00 amRNSAcquisition of PAM Healthcare Limited
9th Feb 20269:04 amRNSHolding(s) in Company
2nd Feb 20264:26 pmRNSHolding(s) in Company
10th Dec 20257:00 amRNSInterim Results
13th Nov 20257:00 amRNSNotice of Half Year Results
6th Nov 20252:17 pmRNSHolding(s) in Company
3rd Nov 20255:14 pmRNSHolding(s) in Company
3rd Nov 202511:15 amRNSHolding(s) in Company
3rd Nov 20257:00 amRNSHalf Year Trading Update
31st Oct 20252:00 pmRNSHolding(s) in Company
31st Oct 202511:06 amRNSHolding(s) in Company
20th Oct 20254:35 pmRNSHolding(s) in Company
29th Sep 20252:06 pmRNSHolding(s) in Company
23rd Sep 20257:00 amRNS-ROptima Health launches Optima Health Ireland
1st Sep 20254:06 pmRNSResult of AGM
4th Aug 202510:31 amRNSHolding(s) in Company
1st Aug 20252:55 pmRNSHolding(s) in Company
30th Jul 20257:00 amRNSNotice of AGM and posting of Annual Report
14th Jul 20253:21 pmRNSHolding(s) in Company
9th Jul 20256:02 pmRNSHolding(s) in Company
8th Jul 20257:00 amRNSFull Year Results
2nd Jul 202512:49 pmRNSHolding(s) in Company
30th Jun 20251:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.